China Health Industr (CHHE) 0.1775 $CHHE
Wholly-Owned Subsidiary of China Health Industries Holdings, Inc. Signed an OEM Contract
Newsfile Corp - Tue Apr 19, 7:00AM CDT
full story)
China Health Industries Holdings, Inc. Achieved Major Technological Breakthrough on Propolis and Black Ant Capsule
ACCESSWIRE - Mon Apr 04, 5:25AM CDT
HARBIN, CHINA / ACCESSWIRE / April 4, 2016 / China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries" or "company"
today announced that the company has achieved a major technological breakthrough on its original product: Propolis and Black Ant Capsule.
China Health Industries Holdings Announces Third Fiscal Quarter Results
Marketwired - Fri May 15, 11:45AM CDT
China Health Industries Holdings, Inc. (OTCQB: CHHE) (the "Company" or "CHHE" today reported that, for the third fiscal quarter of 2015 ended March 31, 2015, the Company had revenue of $1,933,377, a 24 percent decrease on revenue of $2,555,394 for the third fiscal quarter of 2014. This decline was mainly the result of a significant reduction in sales volume of the Company's two leading products, Waterlilies Soft Capsule and Propolis and Black Ant Capsule.
Wholly-Owned Subsidiary of China Health Industries Holdings, Inc. Signed an OEM Contract
Newsfile Corp - Tue Apr 19, 7:00AM CDT
full story)
China Health Industries Holdings, Inc. Achieved Major Technological Breakthrough on Propolis and Black Ant Capsule
ACCESSWIRE - Mon Apr 04, 5:25AM CDT
HARBIN, CHINA / ACCESSWIRE / April 4, 2016 / China Health Industries Holdings, Inc. (OTCQB: CHHE) ("China Health Industries" or "company"
today announced that the company has achieved a major technological breakthrough on its original product: Propolis and Black Ant Capsule. China Health Industries Holdings Announces Third Fiscal Quarter Results
Marketwired - Fri May 15, 11:45AM CDT
China Health Industries Holdings, Inc. (OTCQB: CHHE) (the "Company" or "CHHE"
today reported that, for the third fiscal quarter of 2015 ended March 31, 2015, the Company had revenue of $1,933,377, a 24 percent decrease on revenue of $2,555,394 for the third fiscal quarter of 2014. This decline was mainly the result of a significant reduction in sales volume of the Company's two leading products, Waterlilies Soft Capsule and Propolis and Black Ant Capsule. 
